Hristo P. Varbanov

ORCID: 0000-0003-4450-7332
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metal complexes synthesis and properties
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Ferrocene Chemistry and Applications
  • Lanthanide and Transition Metal Complexes
  • Computational Drug Discovery Methods
  • Synthesis and biological activity
  • Magnetism in coordination complexes
  • Synthesis and Characterization of Heterocyclic Compounds
  • Cancer therapeutics and mechanisms
  • Nanoparticle-Based Drug Delivery
  • Protein Interaction Studies and Fluorescence Analysis
  • Organometallic Complex Synthesis and Catalysis
  • Crystallography and molecular interactions
  • Chronic Myeloid Leukemia Treatments
  • Click Chemistry and Applications
  • Free Radicals and Antioxidants
  • Machine Learning in Materials Science
  • Analytical chemistry methods development
  • Organometallic Compounds Synthesis and Characterization
  • Radioactive element chemistry and processing
  • Cancer Treatment and Pharmacology
  • Nonlinear Optical Materials Research
  • Arsenic contamination and mitigation
  • Advanced biosensing and bioanalysis techniques

Universität Innsbruck
2023-2025

Trakia University
2023-2024

University of Graz
2018-2023

University of Vienna
2009-2021

Institute of Inorganic Chemistry of the Slovak Academy of Sciences
2021

École Polytechnique Fédérale de Lausanne
2015-2019

Medical University of Sofia
2007-2010

Octahedral platinum(IV) complexes are promising candidates in the fight against cancer. In order to rationalize further development of this class compounds, detailed studies on their mechanisms action, toxicity, and resistance must be provided structure–activity relationships drawn. Herein, we report theoretical QSAR investigations a series 53 novel bis-, tris-, tetrakis(carboxylato)platinum(IV) complexes, synthesized tested for cytotoxicity our laboratories. The hybrid DFT functional wb97x...

10.1021/jm3016427 article EN publisher-specific-oa Journal of Medicinal Chemistry 2012-12-10

A series of six novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes was synthesized and characterized in detail by elemental analysis, FT-IR, ESI-MS, HPLC, multinuclear (1H, 13C, 15N, 195Pt) NMR spectroscopy one case X-ray diffraction. Cytotoxic properties the were evaluated four human tumor cell lines originating from ovarian carcinoma (CH1 SK-OV-3), colon (SW480) non-small lung cancer (A549) means MTT colorimetrical assay. In addition, their octanol/water partition...

10.1016/j.ejmech.2011.09.006 article EN cc-by-nc-nd European Journal of Medicinal Chemistry 2011-09-10

The lipophilic character of novel carboplatin prodrugs was controlled by the choice axial ligand also influencing their cytotoxicity.

10.1039/c2dt31366a article EN Dalton Transactions 2012-01-01

A novel class of platinum(IV) complexes the type [Pt(Am)(R(COO)2)2], where Am is a chelating diamine or two monodentate am(m)ine ligands and R(COO)2 dicarboxylato moiety, was synthesized. For this purpose, reaction between corresponding tetrahydroxidoplatinum(IV) precursors various dicarboxylic acids, such as oxalic, malonic, 3-methylmalonic, cyclobutanedicarboxylic acid, utilized. All new compounds were characterized in detail, using 1D 2D NMR techniques, ESI-MS, FTIR spectroscopy,...

10.1021/jm500791c article EN Journal of Medicinal Chemistry 2014-07-17

Advances in treatment strategies together with an earlier diagnosis have considerably increased the average survival of cancer patients over last four decades. Nevertheless, despite growing number new antineoplastic agents introduced each year, there is still no adequate therapy for problematic malignancies such as pancreatic, lung and stomach cancers. Consequently, it important to ensure that existing drugs used treat other types cancers, potentially diseases, are not overlooked when...

10.1371/journal.pone.0171052 article EN cc-by PLoS ONE 2017-02-06

Abstract The selection of drug candidates for entering clinical development relies on in vivo testing (solid) tumor animal models. However, the heterogeneity tissue (e.g. terms uptake or composition) is rarely considered when novel candidates. Therefore, we used murine colon cancer CT-26 model to study spatially-resolved distribution upon repetitive treatment animals over two weeks with three investigational platinum(iv)-based anticancer agents, oxaliplatin satraplatin. A quantitative laser...

10.1039/c5mt00028a article EN Metallomics 2015-03-30

A NanoSIMS, LA-ICP-MS and TEM combinatorial approach was applied to analyze the distribution of platinum( iv ) prodrugs in murine tissue samples.

10.1039/c5sc04383b article EN cc-by Chemical Science 2016-01-01

Lipophilicity is a crucial parameter for drug discovery, usually determined by the logarithmic partition coefficient (Log P) between octanol and water. However, available detection methods have restricted widespread use of in inorganic medicinal chemistry, recent investigations shifted towards chromatographic lipophilicity parameters, frequently without conversion to derive Log P. As high-performance liquid chromatography (HPLC) instruments are readily research groups, HPLC-based method...

10.3390/inorganics6040130 article EN cc-by Inorganics 2018-12-04

Oxaliplatin is stable in pure water and DMSO, but reacts rapidly a mixture of the two solvents.

10.1039/c7dt01628j article EN cc-by Dalton Transactions 2017-01-01

Drug combinations are extensively used to treat cancer and often selected according complementary mechanisms. Here, we describe a cell-based high-throughput screening assay for identification of synergistic between broadly applied platinum-based chemotherapeutics drugs from library composed 1280 chemically pharmacologically diverse (mostly FDA approved) compounds. The was performed on chemoresistant cell lines derived lung (A549) pancreatic (PANC-1) carcinoma, where combination regimens...

10.1371/journal.pone.0211268 article EN cc-by PLoS ONE 2019-01-29

Herein, we present a comparative study on the chemistry and biological activity of N-heterocyclic carbene (NHC)Pt(II)/Au(I) complexes. Accordingly, representative compounds cis/trans- [PtL2X2] (X = Cl (5, 6) or I (7, 8)), [PtL3Cl]+ (9), [AuLX] (10) (11)), [AuL2]+ (12) type, where L is 1,3-diethylbenzimidazol-2-ylidene, were synthesized characterized in detail to elucidate role metal center their physicochemical properties. The stability complexes presence cell culture medium reactivity...

10.3390/inorganics11070293 article EN cc-by Inorganics 2023-07-11

Predicting the solubility and lipophilicity of platinum(II, IV) complexes is essential for prioritizing potential anticancer candidates in drug discovery. This study introduces first publicly available online model predicting platinum complexes, addressing lack literature models this regard. Using a time-split dataset, we developed consensus with Root Mean Squared Error (RMSE) 0.62 through 5-cross-validation on training set 284 historical compounds (solubility data reported prior to 2017)....

10.1016/j.jinorgbio.2025.112890 article EN cc-by-nc-nd Journal of Inorganic Biochemistry 2025-03-10

The reductive biotransformation of platinum( iv ) prodrugs was investigated in whole human blood by HPLC-ICP-MS.

10.1039/c7dt04537a article EN cc-by-nc Dalton Transactions 2018-01-01

Five new multifunctional Pt(<sc>iv</sc>) prodrugs with a carboplatin core and one or two axial deferoxamine ligands were synthesized. The complexes express multiple effects, including cytotoxicity high affinity towards ferric ions.

10.1039/d1dt00214g article EN Dalton Transactions 2021-01-01

Abstract Platinum complexes are a great interest of study, because the antitumor activity and clinical use some them in recent anticancer chemotherapy. In many cases, computational studies can be very useful for predicting structure physicochemical properties metal complexes. Theoretical calculations also used rational design new with optimal ratio: activity/toxicity. The geometry three Pt(II) general formula cis ‐[PtL 2 X ] (where L is 5‐methyl‐5(4‐pyridyl)hydantoin = Cl − , Br I ) free...

10.1002/qua.21890 article EN International Journal of Quantum Chemistry 2008-10-16

(E/Z)-3-(4-((E)-1-(4-Hydroxyphenyl)-2-phenylbut-1-enyl)phenyl)acrylic acid (GW7604) as a carrier was esterified with alkenols of various lengths and coordinated through the ethylene moiety to PtCl3, similar Zeise's salt (K[PtCl3(C2H4)]). The resulting GW7604-Alk-PtCl3 complexes (Alk = Prop, But, Pent, Hex) degraded in aqueous solution only by exchange chlorido ligands. For example, GW7604-Pent-PtCl3 amino alanine cell culture medium, bound isolated nucleotide 5′-GMP, interacted DNA (empty...

10.1021/acs.jmedchem.3c02454 article EN cc-by Journal of Medicinal Chemistry 2024-03-13
Coming Soon ...